Tharimmune, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell THAR and other ETFs, options, and stocks.About THAR
Tharimmune, Inc. is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology. It also develops TH104, which is known to suppress chronic, debilitating pruritus or "uncontrollable itching" in PBC, a rare and orphan liver disease with no known cure.
CEORandy D. Milby
CEORandy D. Milby
Employees2
Employees2
HeadquartersBridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded2017
Founded2017
Employees2
Employees2
THAR Key Statistics
Market cap2.53M
Market cap2.53M
Price-Earnings ratio-0.12
Price-Earnings ratio-0.12
Dividend yield—
Dividend yield—
Average volume11.71K
Average volume11.71K
High today$1.23
High today$1.23
Low today$1.19
Low today$1.19
Open price$1.23
Open price$1.23
Volume7.89K
Volume7.89K
52 Week high$6.45
52 Week high$6.45
52 Week low$0.952
52 Week low$0.952